Effects of unripe Citrus hassaku fruits extract and its flavanone glycosides on blood fluidity

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 4, 2010, Pages 659-664

  Itoh, Kimihisa ^a   Masuda, Megumi ^a   Naruto, Shunsuke ^a   Murata, Kazuya ^a   Matsuda, Hideaki ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Citrus hassaku; Erythrocyte aggregation; Fibrinolysis; Naringenin 7 glycoside; Platelet aggregation

Indexed keywords

AURANTIIN; CITRUS HASSAKU EXTRACT; COLLAGEN; DEXTRAN SULFATE; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FLAVANONE DERIVATIVE; HEPARIN; HERBACEOUS AGENT; HESPERETIN; HESPERIDIN; HEXADIMETHRINE BROMIDE; INDOMETACIN; LIPOPOLYSACCHARIDE; NARINGENIN; NARIRUTIN; NEOHESPERIDIN; PRUNIN; SIALIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; CITRUS FRUIT; CITRUS HASSAKU; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; DRUG DETERMINATION; ERYTHROCYTE AGGREGATION; FIBRINOLYSIS; IN VITRO STUDY; MALE; NONHUMAN; PRIMARY PREVENTION; RABBIT; RAT; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; CITRUS; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE AGGREGATION; ERYTHROCYTES; FIBRIN; FIBRINOGEN; FLAVANONES; FRUIT; GLYCOSIDES; HEMATOLOGIC AGENTS; HEMATOLOGIC TESTS; HEMORHEOLOGY; LIPOPOLYSACCHARIDES; MALE; PLANT EXTRACTS; PLATELET AGGREGATION; RABBITS; RATS; RATS, WISTAR;

EID: 77950892392     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.659     Document Type: Article

References (15)

1. Itoh K., Hirata N., Masuda M., Naruto S., Murata K., Wakabayashi K., Matsuda H., Biol. Pharm. Bull., 32, 410-415 (2009).
2. Itoh K., Masuda M., Naruto S., Murata K., Matsuda H., J. Nat. Med., 63, 443-50 (2009).
3. Yazdanparast R., Shahriyary L., Vascul. Pharmacol., 48, 32-37 (2008).
4. Mekhfi H., Haouari M. E., Legssyer A., Bnouham M., Aziz M., Atmani F., Remmal A., Ziyyat A., J. Ethnopharmacol., 94, 317-322 (2004).
5. Jin Y. R., Han X. H., Zhang Y. H., Lee J. J., Lim Y, Chung J. H., Yun Y. P., Atherosclerosis, 194, 144-152 (2007).
6. Noren I., Ramstrom G., Wallen P., Haemostasis, 4, 110-124 (1975).
7. Astrup T., Mullertz S., Arch. Biochem. Biophys., 40, 346-351 (1952).
8. Chang G. T., Min S. Y., Kim J. H., Kim S. H., Kim J. K., Kim C. H., Vascul. Pharmacol., 43, 283-288 (2005).
9. Schoendorf T. H., Rosenberg M., Beller F. K., Am. J. Pathol., 65, 51-58 (1971).
10. Born G. V. R., Cross M. J., J. Physiol., 168, 178-195 (1963).
11. Sabio H., Levien M., Atkinson S., Thromb. Res., 29, 537-540 (1983).
12. Chuang C. C., Wen W. C., Sheu S. J., J. Sep. Sci., 30, 1235-1241 (2007).
13. Zhang C., Lu Y., Tao L., Tao X., Su X., Wei D., J. Enzyme Inhib. Med. Chem., 22, 83-90 (2007).
14. Hasegawa M., Shirato T., J. Am. Chem. Soc., 74, 6114-6115 (1952).
15. Fujita T., Kawase A., Nishijima N., Masuda M., Matsuda H., Iwaki M., Shoyakugaku Zasshi, 62, 8-14 (2008).